en
jalali
1396
10
1
gregorian
2018
1
1
9
1
online
1
fulltext
en
Digesters in traditional Persian medicine
Background: Functional gastrointestinal diseases are common in general populations and comprise more than 40% visits to gastroenterologists. Treatment options of gastrointestinal diseases have been limited. There are a few medications for functional gastrointestinal diseases and some of medications are not available in the market or in the place where the patient lives. Traditional Persian medicine (TPM) is a branch of alternative and traditional medicine based on individual viewpoint and humoral theory, focuses on lifestyle modification and uses natural products to manage the patients.
Methods: In this study, a set of compound drugs known as digesters (jawarishes) and other applications are described based on main TPM text books.
Results: Jawarishes have different formulations containing various medicinal herbs used for better food digestion and improved gastric functions and also used for other disorders including reinforcing the brain, heart, liver and some therapeutic approaches.
Conclusions: By reviewing medieval Persian pharmaceutical manuscripts, we can conclude that many herbs are effective in different systems of the body and improve gastric functions. Zingiber officinalis and Piper nigrum are mixed together to get various formulations. The variety of jawarishes formulations and their different clinical applications can indicate continuity of their use.
Gastrointestinal tract, Herbal medicine, Jawarish
1
6
http://caspjim.com/browse.php?a_code=A-10-698-1&slc_lang=en&sid=1
2017/01/23
1395/11/4
2017/09/23
1396/7/1
Zeinab
Mahmoudpour
Department of Persian Medicine, School of Persian Medicine, Babol University of Medical Sciences, Babol, Iran
mahmoudpour.zeinab@gmail.com
00319475328460011315
00319475328460011315
No
Hoda
Shirafkan
Department of Epidemiology and Biostatistics, School of Public health, Tehran University of Medical Sciences, Tehran, Iran
hodashirafkan@gmail.com
00319475328460011316
00319475328460011316
No
Morteza
Mojahedi
Department of History of Medical Sciences, School of Persian Medicine, Babol University of Medical Sciences, Babol, Iran
mortazamojahedy@gmail.com
00319475328460011317
00319475328460011317
No
Narjes
Gorji
Traditional Medicine and History of Medical Sciences Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
nargess_gorji@yahoo.com
00319475328460011318
00319475328460011318
No
Seyyed Ali
Mozaffarpur
Social Determent Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
seyyedali1357@gmail.com
00319475328460011319
00319475328460011319
Yes
en
A systematic review on reminder systems in physical therapy
Background: The main goal of physical therapy is to help the patient gain a better health status. Several studies have investigated the use of reminders to prevent such failures on the patients’ side. This article presents a systematic review of the literature concerning reminders in physical therapy.
Methods: Databases were searched until May 2017 and literatures were found from April 1992 until 2017. The literature recruitment strategy was based on applying several keywords and Medical Subject Heading (MeSH) combination running against title and abstract, including concepts such as reminder, physical therapy. The finally selected articles were categorized through reminder aspects such as how, who feedback. Data were extracted according to PRISMA guidelines.
Results: In 47% of studies, the reminder was sent to the patients, 29% to the physical therapists and 12% to the caretaker team. In 24% of the studies, paper-based letters were main medium for reminders while the rest were various types of media like emails and SMS mobile text messages. 35% of the articles showed positive effects of the reminders.
Conclusions: Many reminder methods consisted of SMS, phone calls, letters, emails and notices on the wall were used in physical therapy. Reminders may be used to improve patients' adherence to exercise programs.
Reminder, Physical therapy, Systematic review
7
15
http://caspjim.com/browse.php?a_code=A-10-757-1&slc_lang=en&sid=1
2017/01/232017/04/16
1396/1/27
2017/09/232017/09/23
1396/7/1
Majid
Jangi
Department of Medical Informatics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Jangim922@mums.ac.ir
00319475328460010967
00319475328460010967
No
Cesar
Fernández-de-las-Peñas
Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos, Alcorcón, Madrid, Spain
cesar.fernandez@urjc.es
00319475328460010968
00319475328460010968
No
Mahmoud
Tara
. Department of Medical Informatics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Taram@mums.ac.ir
00319475328460010969
00319475328460010969
No
Fateme
Moghbeli
. Department of Health Information Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
fateme.moghbeli@gmail.com
00319475328460010970
00319475328460010970
No
Fariba
Ghaderi
Department, Faculty of Rehabilitation, Tabriz University of Medical Sciences, Tabriz, Iran
ghaderif@tbzmed.ac.ir
00319475328460010971
00319475328460010971
No
Khodabakhsh
Javanshir
Mobility Impairment Research Center, Health Research Institate, Babol University of Medical Sciences, Babol Iran
kjavanshir@yahoo.com
00319475328460010972
00319475328460010972
Yes
en
Trends in epidemiology of Hepatitis B and C Infections in Ilam Province: National Notifiable Diseases Surveillance System data
Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are the main causes of severe liver failure worldwide. This study was conducted to evaluate the incidence rate and trend of these infections over six successive years from 2008 to 2013 in Ilam Province, western Iran.
Methods: We studied the registered data of HBV and HCV based on the National Notifiable Diseases Surveillance System in Ilam Province from 2008 to 2013. Incidence rate per 100,000 populations was estimated for HBV and HCV infections through location, years and age groups of patients.
Results: The overall incidence rate per 100,000 populations from 2008 to 2013 for HBV infection was 9.57, 5.83, 16.26, 12.44, 21.89 and 13.93, respectively. The corresponding values for HCV infection were 0.55, 0.72, 1.44, 2.69, 1.24 and 1.93, respectively and these trends for both the HBV and HCV infections were increasing. The major distribution of HBV and HCV infections was 25-44 years of age. Both HBV and HCV infections were more common in males, urban areas and married patients. Forty-one percent of cases were carriers and history of surgery was the common risk factor.
Conclusions: Our results showed that HBV and HCV are prevalent in the middle-age group. Despite effective vaccination against hepatitis B, optimized blood donor screening and better sterilization procedures for blood products, trend of HBV and HCV in Ilam are increasing. Further studies should address the role other risk factors in the trend of HBV and HCV.
Hepatitis B, Hepatitis C, Incidence, Trend, Iran
16
21
http://caspjim.com/browse.php?a_code=A-10-565-3&slc_lang=en&sid=1
2017/01/232017/04/162016/10/21
1395/7/30
2017/09/232017/09/232017/04/29
1396/2/9
Salman
Khazaei
Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
salman.khazaei61@gmail.com
00319475328460011207
00319475328460011207
No
Manoochehr
Karami
Modeling of Noncommunicable Diseases Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
m.karami@yahoo.com
00319475328460011208
00319475328460011208
No
Erfan
Ayubi
Department of Community Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
aubi655@gmail.com
00319475328460011209
00319475328460011209
No
Abolfazl
Mohammadbeigi
Gastroenterology & Hepatology Diseases Research Center, Qom University of Medical Sciences, Qom, Iran
beigi60@gmail.com
00319475328460011210
00319475328460011210
No
Azim
Hasanbeigi
Deputy of Health, Ilam University of Medical Sciences, Ilam, Iran
azim1836@yahoo.com
00319475328460011211
00319475328460011211
Yes
Kamyar
Mansori
Department of Public Health, School of Public Health, Dezful University of Medical Sciences, Dezful, Iran
kamyarmansorii@yahoo.com
00319475328460011212
00319475328460011212
No
Mohammad Reza
Mir-Shekar
Deputy of Health, Ilam University of Medical Sciences, Ilam, Iran
mirsekar63@yahoo.com
00319475328460011213
00319475328460011213
No
en
Risk factors of hepatitis B virus infection among blood donors in Duhok city, Kurdistan Region, Iraq
Background: Hepatitis B virus (HBV) infection is a public health problem. The lack of information about the seroprevalence and risk factors is an obstacle for preventive public health plans to reduce the burden of viral hepatitis. Therefore, this study was conducted in Iraq, where no studies had been performed to determine the prevalence and risk factors of HBV infection.
Methods: Blood samples were collected form 438 blood donors attending blood bank in Duhok city. Serum samples were tested for HBV core-antibodies (HBcAb) and HBV surface-antigen (HBsAg) by ELISA. Various risk factors were recorded and multivariate analysis was performed.
Results: 5/438 (1.14%) of the subjects were HBsAg positive (HBsAg and HBcAb positive) and 36/438 (8.2%) were HBcAb positive. Hence, 41 cases were exposed to HBV and data analysis was based on that. Univariate analysis showed that there were significant associations between history of illegitimate sexual contact, history of alcohol or history of dental surgeries and HBV exposure (p<0.05 for all). Then, multivariate analysis was conducted to find HBV exposure predictive factors. It was found that history of dental surgery was a predictive factor for exposure to the virus (P=0.03, OR: 2.397).
Conclusions: This study suggested that the history of dental surgery was predictive for HBV transmission in Duhok city. Further population-based study is needed to determine HBV risk factors in the society and public health plan based on that should be considered
HBV, Iraq, Duhok, Risk factors
22
26
http://caspjim.com/browse.php?a_code=A-10-577-1&slc_lang=en&sid=1
2017/01/232017/04/162016/10/212016/07/9
1395/4/19
2017/09/232017/09/232017/04/292017/05/1
1396/2/11
Nawfal
Hussein
Department of Internal Medicine, College of Medicine, University of Duhok, Duhok, Kurdistan Region, Iraq.
nawfal.hussein@yahoo.com
00319475328460011096
00319475328460011096
Yes
en
Anti-coagulation therapy following coronary endarterectomy in patient with coronary artery bypass graft
Background: Since there is a lack of research on postoperative anticoagulation protocol in patients undergoing coronary artery bypass graft (CABG) / coronary endarterectomy (CE), we recommend a new protocol for anticoagulation in these patients.
Methods: In this double-blind randomized clinical trial study, 52 patients undergoing CABG / CE entered the study and were divided into two groups. In group 1, the patients were given warfarin(international normalized ratio (INR) between 2-3) together with 80 mg aspirin daily for 3 months. In group 2, the patients were given 75 mg plavix daily together with 80 mg aspirin daily for 3 months. We evaluated patients with electrocardiography, echocardiography and checking ceratin phosphokinase MB and troponin I in the several stages. The data were analysed SPSS Version18 software.
Results: There was no significant difference between pre and post-operative Ejection fraction in patients with plavix (P=0.21) and warfarin (P=0.316) regimen. However, wall mrotion score was significantly better in clopidogrel – aspirin patients in late (3 months) post operation (p<0.001).
Conclusions: Since warfarin has serious hemorrhagic complications and requires closed monitoring of serum drug activity by serial INR checking, it is recommended that clopidogrel – aspirin can be the preferred alternative anticoagulation therapy in CABG / CE patients.
Coronary artery bypass graft, Coronary endarterectomy, Warfarin, Clopidogrel
27
31
http://caspjim.com/browse.php?a_code=A-10-679-1&slc_lang=en&sid=1
2017/01/232017/04/162016/10/212016/07/92017/01/19
1395/10/30
2017/09/232017/09/232017/04/292017/05/12017/05/7
1396/2/17
Hamid Reza
Vafaey
Department of Cardiac Surgery, Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
Hamidreza.vafaey@yahoo.com
00319475328460011091
00319475328460011091
No
Mohammad Taghi
Salehi Omran
Department of Cardiology, Ayatollah Rouhani hospital, Babol University of Medical Sciences, Babol, Iran.
tomran40@yahoo.com
00319475328460011092
00319475328460011092
No
Sadaf
Abbaspour
Student Research Committee, Babol University of Medical Sciences, Babol, Iran
sdfpour@yahoo.com
00319475328460011093
00319475328460011093
No
Nadia
Banihashem
Department of Anesthesiology, Babol University of Medical Sciences, Babol, Iran
nbanihashem@yahoo.com
00319475328460011094
00319475328460011094
No
Ghassem
Faghanzadeh Ganji
Department of Cardiac Surgery , Ayatollah Rohani Hospital, Babol University of Medical Sciences, Babol , Iran
ghf.ganji@yahoo.com
00319475328460011095
00319475328460011095
Yes
en
Analgesic effects of lidocaine-ketorolac compared to lidocaine alone for intravenous regional anesthesia
Background: Intravenous regional anesthesia is a simple and reliable method for upper extremity surgery. In order to increase the quality of blocks and reduce the amount of pain, many drugs are used with lidocaine. In this study, the effect of ketorolac-lidocaine in intravenous regional anesthesia was investigated.
Methods: 40 patients undergoing elective upper limb with America Society of Anesthesiologists class I and II were selected and randomly divided into two groups. The first group of 20 patients received 200 mg of lidocaine, and the second group, 200 mg of lidocaine with 20 mg of ketorolac. In both groups, the drug was diluted to 40 ml. In both groups, the onset of sensory block, onset of tourniquet pain, the onset of pain after opening the tourniquet, score of postoperative pain and analgesic prescription in the first 24 hours, during 1, 6, 12 and 24 hours were studied. A measure of the quality of analgesia was evaluated by VAS.
Results: The mean onset of tourniquet pain in the two groups was not significantly different (P=0.443). In the ketorolac group, the onset of pain after opening the tourniquet was significantly longer than lidocaine group (p<0.001). The mean postoperative pain score during the first 24 hours after surgery in the ketorolac group was significantly lower than lidocaine group (p<0.001). The average number of analgesia prescription during the 24 hours after operation was significantly lower in ketorolac group than lidocaine group (p<0.001).
Conclusions: Adding ketorolac to lidocaine for regional anesthesia can reduce the postoperative pain for up to 24 hours after opening the tourniquet.
Lidocaine, ketorolac, pain, Intravenous regional anesthesia
32
37
http://caspjim.com/browse.php?a_code=A-10-513-1&slc_lang=en&sid=1
2017/01/232017/04/162016/10/212016/07/92017/01/192016/04/3
1395/1/15
2017/09/232017/09/232017/04/292017/05/12017/05/72017/07/22
1396/4/31
Shahram
Seyfi
Cancer Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
ficu_ss@yahoo.com
00319475328460012592
00319475328460012592
No
Nadia
Banihashem
Department of Anesthesiology, Clinical Research Development Unit, Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran
nbanihashem@yahoo.com
00319475328460012593
00319475328460012593
No
Ali
Bijani
Non-Communicable Pediatric Diseases Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
00319475328460012594
00319475328460012594
No
Karimollah
Hajian-Tilaki
Social determinat Health ResearchCenter, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
drhajian@yahoo.com
00319475328460012595
00319475328460012595
No
Mohsen
Daghmehchi
Student Research Committee, Babol University of Medical Sciences, Babol, Iran
rohanresearch88@gmail.com
00319475328460012596
00319475328460012596
Yes
en
Acupuncture for chronic nonpulsatile tinnitus: A randomized clinical trial
Background: There is challenge to find an effective treatment for tinnitus. Few studies were done on the effects of acupuncture on tinnitus. This study evaluated the effect of acupuncture on chronic non-pulsatile tinnitus.
Methods: This randomized double-blind clinical trial was conducted from December 2014 to September 2015. Patients suffering from chronic non-pulsatile tinnitus were randomly allocated into two groups: acupuncture vs. placebo. They were treated in 15 sessions and at the end of the fifteenth sessions and 3 weeks after completion of the treatment, visual analog scale (VAS) for tinnitus loudness and tinnitus severity index (TSI) questionnaires were completed.
Results: The case group included 26 males and 18 females, and in the control group there were 27 males and 17 females: with mean age of 49.11±1.07 and 55.20±8.33 years, respectively (p=0.005). TSI and VAS before treatment were 43.84±2.81 and 9.56±0.43 in cases and 43.52±2.94 and 9.54±0.45 in controls, respectively. Both measures improved after 15 sessions in cases to 24.82±1.04 and 2.88±0.33, and to 33.16±1.24 and 7.86±0.23 in controls. The changes of TSI and VAS were significant in all groups (p<0.001). TSI and VAS in acupuncture group were lower than placebo group in each session (p<0.001), except TSI in the tenth session (p=0.392).
Conclusions: Acupuncture is effective in reducing the loudness and severity of tinnitus and can be a useful treatment for nonpulsatile chronic tinnitus
Tinnitus, Acupuncture, Severity, Loudness
38
45
http://caspjim.com/browse.php?a_code=A-10-602-2&slc_lang=en&sid=1
2017/01/232017/04/162016/10/212016/07/92017/01/192016/04/32016/12/3
1395/9/13
2017/09/232017/09/232017/04/292017/05/12017/05/72017/07/222017/03/12
1395/12/22
Bahram
Naderinabi
Department of Anesthesiology. Anesthesiology Research Center, Guilan University of Medical Sciences, Rasht, Iran
Naderi_bahram@yahoo.com
00319475328460011102
00319475328460011102
No
Soheil
Soltanipour
Department of Community Medicine, Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran
ssoltanipour@yahoo.com
00319475328460011103
00319475328460011103
No
Shadman
Nemati
Rhino-sinus Research Center, Gilan University of Medical Sciences, Rasht , Iran
drshadmannemati_ent@yahoo.com
00319475328460011104
00319475328460011104
No
Alia
Saberi
Neurosciences Research Center, Neurology Department, Poursina Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Ira
alia.saberi@gmail.com
00319475328460011105
00319475328460011105
Yes
Sepideh
Parastesh
Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran
sepideh.parastesh@yahoo.com
00319475328460011106
00319475328460011106
No
en
The efficacy and safety of two different doses of caffeine in respiratory function of preterm infants
Background: Caffeine is widely used for prevention of apnea and helps successful extubation from mechanical ventilation. It facilitates the transition from invasive to noninvasive support and reduces duration of continuous positive airway pressure (CPAP) in preterm infants. The optimum caffeine dose in preterm infants has not been well-studied in terms of benefits and risks. We compared efficacy and safety of once versus twice-daily caffeine dose in premature infants.
Methods: This study was a randomized clinical trial conducted in Bu-Ali Sina Teaching Hospital, Sari. Patients with gestational age of <37 weeks were included. Both groups received 20 mg/kg loading dose of caffeine intravenously followed by maintenance dose of 5 mg/kg/day in group 1 or 2.5 mg/kg every 12 hours in group 2. Extubation failure, CPAP failure and possibly adverse reactions were evaluated.
Results: The mean of gestational age and birth weight were 32.27±3.23 (weeks) and 1824.5±702.54 (gr), respectively. The rate of extubation and CPAP failure and length of NICU stay were lower in twice-daily-group with no statistically significant difference. The means of O2 saturations on the first three days of caffeine therapy were higher in twice-daily-group. Caffeine was generally safe and well tolerated.
Conclusions: This study, which assayed short-term effects of caffeine, showed that twice daily caffeine maintenance dose was related to more benefits in facilitating extubation or prevention of CPAP failure in preterm infants. However, there was not statistically significant difference between two groups.
Caffeine, Extubation failure, CPAP failure, Preterm infants
46
53
http://caspjim.com/browse.php?a_code=A-10-686-1&slc_lang=en&sid=1
2017/01/232017/04/162016/10/212016/07/92017/01/192016/04/32016/12/32017/01/3
1395/10/14
2017/09/232017/09/232017/04/292017/05/12017/05/72017/07/222017/03/122017/05/13
1396/2/23
Fatemeh
Faramarzi
Department of Clinical Pharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
faramarzif1984@gmail.com
00319475328460011107
00319475328460011107
No
Mohamadreza
Shiran
Immunogenetics Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
Mr.Shiran@gmail.com
00319475328460011108
00319475328460011108
No
Mohamadreza
Rafati
Department of Clinical Pharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
mrrafati@mazums.ac.ir
00319475328460011109
00319475328460011109
Yes
Roya
Farhadi
Department of Pediatrics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
dr.royafarhadi@gmail.com
00319475328460011110
00319475328460011110
No
Ebrahim
Salehifar
Department of Clinical Pharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
00319475328460011111
00319475328460011111
No
Maryam
Nakhshab
Department of Pediatrics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
00319475328460011112
00319475328460011112
No
en
Relationship between β-Thalassemia minor and Helicobacter pylori infection
Background: Until now, no study has been reported investigating the association between β-thalassemia minor and Helicobacter pylori (H. pylori) infection. This study was designed to compare H. pylori infection rate between β-thalassemia minor patients and healthy controls.
Methods: A number of 100 β-thalassemia minor patients (50 males, 50 females) and 100 gender-matched healthy controls were prospectively recruited in this study in a period of 3 months. The study population consisted of the people who referred to a health center in Babol, North of Iran, for premarital counseling. H. pylori status was assessed by measuring the anti-H. pylori IgG antibodies using enzyme-linked immunosorbent assay. Demographic information and informed consent were collected from all participants.
Results: The overall H. pylori infection rate was 43%. The infection was significantly more prevalent in thalassemia patients (53%) than in the controls (33%) in both univariate (OR=2.29, 95% CI: 1.3-4.06) and multivariable analyses (OR=2.05, 95% CI: 1.12-3.76). Age was the only significant factor which was positively correlated with the infection in β-thalassemia minor cases (OR=1.11, 95% CI: 1.02-1.2). Gender, blood groups, residency, and education level were not related to the infection.
Conclusions: According to the results, it can be concluded that β-thalassemia minor patients are possibly more susceptible to H. pylori infection than healthy people. Further studies are needed to discover more about the exact mechanisms of increased susceptibility to H. pylori infection in β-thalassemia minor patients
Helicobacter pylori, thalassemia minor, prevalence
54
59
http://caspjim.com/browse.php?a_code=A-10-120-7&slc_lang=en&sid=1
2017/01/232017/04/162016/10/212016/07/92017/01/192016/04/32016/12/32017/01/32017/05/12
1396/2/22
2017/09/232017/09/232017/04/292017/05/12017/05/72017/07/222017/03/122017/05/132017/06/13
1396/3/23
Mohammad
Zamani
Student Research Committee, Babol University of Medical Sciences, Babol, Iran
mzamani20@gmail.com
00319475328460011113
00319475328460011113
No
Amin
Vahedi
Student Research Committee, Babol University of Medical Sciences, Babol, Iran
aminvahedi@hotmail.com
00319475328460011114
00319475328460011114
No
Ahmad
Tamaddoni
Non-Communicable Pediatric Diseases Research Center, Babol University of Medical Sciences, Babol, Iran
drtamaddoni@yahoo.com
00319475328460011115
00319475328460011115
No
Ali
Bijani
Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
alibijani@yahoo.com
00319475328460011116
00319475328460011116
No
Mojgan
Bagherzade
Department of Immunology, Babol University of Medical Sciences, Babol, Iran
mojan73@yahoo.com
00319475328460011117
00319475328460011117
No
Javad
Shokri-Shirvani
Department of Internal Medicine, Rohani Hospital, Babol University of Medical Sciences, Babol, Iran
javadshokry@gmail.com
00319475328460011118
00319475328460011118
Yes
en
Fecal calprotectin Level in patients with IBD and noninflammatory disease of colon: a study in Babol, Northern, Iran
Background: Inflammatory bowel disease (IBD) is a chronic disease with a relapsing course of inflammation in the digestive system. Endoscopy and histopathology are the golden standard methods for detection and assessment of IBD. A distinct increase of fecal calprotectin level can be a useful marker for the diagnosis of IBD. The aim of this study was to evaluate the fecal calprotectin level in patients with IBD and without inflammatory diseases of the colon.
Methods: Calprotectin levels of patients referred to the Ayatollah Rouhani Hospital of Babol, northern Iran with clinical symptoms of colon disease were evaluated. After a week, colonoscopy and biopsy were performed on all patients and they were divided into two groups. The first group included patients with confirmed IBD and the second group included patients with diseases other than IBD, patients with IBS and healthy persons. Then the measured fecal calprotectin level was compared between the two groups before colonoscopy.
Results: We observed correlation between calprotection in these two groups (p<0.0001). 38 (86.8%) patients in the case group and 5 (13.2%) patients in the control group had positive fecal calprotectin test and 12 (23.1%) patients in the case group and 40 (76.9%) patients in the control group had negative results. Basad on ROC curve, the cutoff point of calprotectin was 127.65 with 73% sensitivity and 89% specificity. The area under the curve was 0.83 with 95% confidence interval, 0.74-0.91 (p<0.0001).
Conclusions: The results pointed to this fact that fecal calprotectin can be a noninvasive marker in differentiating IBD from IBS
Fecal calprotectin level, Inflammatory bowel disease, Irritable bowel syndrome
60
64
http://caspjim.com/browse.php?a_code=A-10-349-1&slc_lang=en&sid=1
2017/01/232017/04/162016/10/212016/07/92017/01/192016/04/32016/12/32017/01/32017/05/122015/04/22
1394/2/2
2017/09/232017/09/232017/04/292017/05/12017/05/72017/07/222017/03/122017/05/132017/06/132017/08/12
1396/5/21
Majid
Sharbatdaran
Cancer Research Center, Health Research Institute, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran
bcrdc90@yahoo.com
00319475328460011119
00319475328460011119
No
Amin
Halakou
Department of pathology, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran
dr.amin.halakou@gmail.com
00319475328460011120
00319475328460011120
No
Mehrdad
Kashifard
Cancer Research Center, Health Research Institute, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran
bcrdc90@yahoo.com
00319475328460011121
00319475328460011121
No
Ali
Bijani
Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
bcrdc90@yahoo.com
00319475328460011122
00319475328460011122
No
Alireza
Firozjaei
Cancer Research Center, Health Research Institute, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran
bcrdc90@yahoo.com
00319475328460011123
00319475328460011123
No
Akram
Hossaini
Cancer Research Center, Health Research Institute, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran
bcrdc90@yahoo.com
00319475328460011124
00319475328460011124
No
Sepideh
Siadati
Cancer Research Center, Health Research Institute, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran
bcrdc90@yahoo.com
00319475328460011125
00319475328460011125
Yes
en
BCR-ABL fusion genes and laboratory findings in patients with chronic myeloid leukemia in northeast Iran
Background: A specific chromosomal abnormality, the Philadelphia chromosome (BCR-ABL fusion), is present in all patients with chronic myeloid leukemia (CML). The b2a2 and b3a2 fusion mRNAs encode p210 fusion protein p210 and e1a2 encode p190. The aim of this study was to evaluate the frequency of BCR-ABL fusion transcript variants in Northeast of Iranian CML patients and to compare the laboratory results of our patients.
Methods: This study was conducted in 85 peripheral blood and bone marrow samples of CML patients. Ribonucleic acid (RNA) was extracted by a commercial kit, RT- PCR for identifying BCR-ABL fusions was carried out by using designed primers and the PCR products were electrophoresed in agarose gels. Finally, statistical analysis was performed for variant frequency identification and their comparison was performed.
Results: All patients examined were positive for BCR/ABL rearrangement. Fusion of b3a2 was detected in 53 (62.35%) patients, b2a2 in 25 (29.41), e1a2 in 1 (1.17%) and coexpression of b3a2 and e1a2 in 6 (7.05%) patients. There were significant differences between the mean age in patients with b3a2 positive ( 44.07 years) and in b3a2 negative group (50.35 years) however, no significant differences were seen between sex and b2a2 (P=0.61), b3a2 (P=0.79) and e1a2 (P=0.20).
Conclusions: This study showed higher frequency b3a2 than b2a2 and e1a2 transcripts in CML patients in Northeast Iran and there was no association between e1a2 transcripts frequencies and monocytosis in peripheral blood
BCR-ABL, RT-PCR, chronic myeloid leukemia, Iran
65
70
http://caspjim.com/browse.php?a_code=A-10-588-1&slc_lang=en&sid=1
2017/01/232017/04/162016/10/212016/07/92017/01/192016/04/32016/12/32017/01/32017/05/122015/04/222016/07/24
1395/5/3
2017/09/232017/09/232017/04/292017/05/12017/05/72017/07/222017/03/122017/05/132017/06/132017/08/122017/08/19
1396/5/28
Hossein
Ayatollahi
Cancer Molecular Pathology Research Center, Department of Hematology and Blood Bank, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
ayatollahih@mums.ac.ir
00319475328460011147
00319475328460011147
No
Mohammadreza
Keramati
Cancer Molecular Pathology Research Center, Department of Hematology and Blood Bank, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
keramatimr@mums.ac.ir
00319475328460011148
00319475328460011148
No
Abbass
Shirdel
Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
SHIRDELA@MUMS.AC.IR
00319475328460011149
00319475328460011149
No
Mohammadmehdi
Kooshyar
Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
kooshyarmm@mums.ac.ir
00319475328460011150
00319475328460011150
No
Majid
Raeiszadeh
Cancer Molecular Pathology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
raeiszadehm2@mums.ac.ir
00319475328460011151
00319475328460011151
No
Sepideh
Shakeri
Cancer Molecular Pathology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
ssh.shakeri@gmail.com
00319475328460011152
00319475328460011152
No
Mohammadhadi
Sadeghian
Cancer Molecular Pathology Research Center, Department of Hematology and Blood Bank, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
sadeghianmh@mums.ac.ir
00319475328460011153
00319475328460011153
Yes
Fatemeh
Shams
Cancer Molecular Pathology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
shams8869@yahoo.com
00319475328460011154
00319475328460011154
No
en
Tumor necrosis factor- α, adiponectin and their ratio in gestational diabetes mellitus
Background: It has been suggested that inflammation might be implicated in the gestational diabetes mellitus (GDM) complications, including insulin resistance. The aims of the current study were to explore maternal circulating values of TNF-α, adiponectin and the adiponectin/TNF-α ratio in women with GDM compared with normal pregnancy and their relationships with metabolic syndrome biomarkers.
Methods: Forty women with GDM and 40 normal pregnant women were included in the study. Commercially available enzyme-linked immunosorbent assay methods were used to measure serum levels of TNF-α and total adiponectin.
Results: Women with GDM had higher values of TNF-α (225.08±27.35 vs 115.68±12.64 pg/ml, p<0.001) and lower values of adiponectin (4.50±0.38 vs 6.37±0.59 µg/ml, P=0.003) and the adiponectin/TNF-α ratio (4.31±0.05 vs 4.80±0.07, P<0.001) than normal pregnant women. The adiponectin/TNF-α ratio showed negative correlations with insulin resistance (r=-0.68, p<0.001) and triglyceride (r=-0.39, P=0.014) and a positive correlation with insulin sensitivity (r=0.69, p<0.001). Multiple linear regression analysis showed that values of the adiponectin /TNF-α ratio were independently associated with insulin resistance. Binary logistic regression analysis showed that GDM was negatively associated with adiponectin /TNF-α ratio.
Conclusions: In summary, the adiponectin/TNF-α ratio decreased significantly in GDM compared with normal pregnancy. The ratio might be an informative biomarker for assessment of pregnant women at high risk of insulin resistance and dyslipidemia and for diagnosis and therapeutic monitoring aims in GDM
Gestational diabetes mellitus, Adiponectin, Tumor necrosis factor- α, Insulin resistance
71
77
http://caspjim.com/browse.php?a_code=A-10-598-2&slc_lang=en&sid=1
2017/01/232017/04/162016/10/212016/07/92017/01/192016/04/32016/12/32017/01/32017/05/122015/04/222016/07/242017/04/3
1396/1/14
2017/09/232017/09/232017/04/292017/05/12017/05/72017/07/222017/03/122017/05/132017/06/132017/08/122017/08/192017/06/18
1396/3/28
Ali
Khosrowbeygi
Department of Biochemistry and Genetics, School of Medicine, Arak University of Medical Sciences, Arak, Iran
a.khosrowbeygi@arakmu.ac.ir
00319475328460011159
00319475328460011159
Yes
Mohammad Reza
Rezvanfar
Department of Internal Medicine, Arak University of Medical Sciences, Arak, Iran
rezvanfar@gmail.com
00319475328460011160
00319475328460011160
No
Hassan
Ahmadvand
Department of Biochemistry, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
hassan_a46@yahoo.com
00319475328460011161
00319475328460011161
No
en
Development and validation of a Semi-quantitative food frequency questionnaire among older people in north of Iran
Background: The study was conducted to assess reliability of modified semi-quantitative food frequency questionnaire (SQFFQ) as a part of the Amirkola Health and Aging Project (AHAP).
Methods: The study was carried out in a sample of 200 men and women aged 60 years and older. A 138-item SQFFQ and two 24-hour dietary recalls were completed. The reliability of SQFFQ was evaluated by comparing eighteen food groups, energy and nutrient intakes derived from both methods using Spearman and Pearson’s correlation coefficients for food groups and nutrients, respectively. Bland-Altman plots and Pitman’s tests were applied to compare the two dietary assessment methods.
Results: The mean (SD) age of subjects was 68.16 (6.56) years. The average energy intake from 24-hour dietary recalls and the SQFFQ were 1470.2 and 1535.4 kcal/day, respectively. Spearman correlation coefficients, comparing food groups intake based on two dietary assessment methods ranged from 0.25 (meat) to 0.62 (tea and coffee) in men and from 0.39 (whole grains) to 0.60 (sugars) in women. Pearson correlation coefficients for energy and macronutrients were 0.53 for energy to 0.21 for zinc in male and 0.71 for energy to 0.26 for vitamin C in females. The Pitman’s test reflected the reasonable agreement between the mean energy and macronutrients of the SQFFQ and 24-hour recalls.
Conclusions: The modified SQFFQ that was designed for the AHAP was found to be reliable for assessing the intake of several food groups, energy, micro-and macronutrients.
Reliability, Semi quantitative food frequency questionnaire, Cohort study, Elderly
78
86
http://caspjim.com/browse.php?a_code=A-10-95-4&slc_lang=en&sid=1
2017/01/232017/04/162016/10/212016/07/92017/01/192016/04/32016/12/32017/01/32017/05/122015/04/222016/07/242017/04/32017/08/7
1396/5/16
2017/09/232017/09/232017/04/292017/05/12017/05/72017/07/222017/03/122017/05/132017/06/132017/08/122017/08/192017/06/182017/10/30
1396/8/8
Ali
Bijani
Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
alibijani@yahoo.com
00319475328460011286
00319475328460011286
No
Haleh
Esmaili
Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
Bijani.ali@gmail.com
00319475328460011287
00319475328460011287
No
Reza
Ghadimi
Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
rezaghadimi@yahoo.com
00319475328460011288
00319475328460011288
Yes
Atekeh
Babazadeh
Mobility Impairment Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
Bijani.ali@gmail.com
00319475328460011289
00319475328460011289
No
Reyhaneh
Rezaei
Cancer Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
Bijani.ali@gmail.com
00319475328460011290
00319475328460011290
No
Robert G
Cumming
School of Public Health, University of Sydney, Sydney, Australia
Bijani.ali@gmail.com
00319475328460011291
00319475328460011291
No
Seyed-Reza
Hosseini
Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
Hosseinirezaseyed@gmail.com
00319475328460011292
00319475328460011292
No
en
Stimulant use in medical students and residents requires more careful attention
Background: Stimulant pharmaceuticals are abused among academic students to elevate mood, improve studying, intellectual capacity, memory and concentration, and increase wakefulness. This study was designed to evaluate the current situation of stimulant use among medical students and residents of Babol University of Medical Sciences.
Methods: This cross-sectional study was conducted among 560 medical students and clinical residents of Babol University of Medical Sciences during the academic year 2014-2015. A self-administered questionnaire was used for data collection.
Results: Four hundred and forty-four (79.3%) students filled out the questionnaires. 49 (11%) individuals reported amphetamine and methylphenidate (ritalin) use. The mean age of the stimulant drug users was 24.6±4.8 years. The main initiator factor was to improve concentration (29 persons; 59.2%). There were significant statistical correlations between stimulant drugs abuse and male gender, living in dormitor in residence and internship and past medical history of psychiatric disorders (depression, attention deficit hyperactivity disorder and substance abuse) (p<0.05).16 (32%) students started the drug use on their friends’ advice; 15 (30%) due to self-medication and 12 (24%) persons with physician´s prescription.
Conclusions: Because of significant prevalence of stimulant use, regulatory governmental policies and also planning to improve essential life skills, awareness about the side effects and complications of these drugs, screening of at-risk college students and early identification of the abusers are suggested
Stimulants, Medical students, Residents
87
91
http://caspjim.com/browse.php?a_code=A-10-113-1&slc_lang=en&sid=1
2017/01/232017/04/162016/10/212016/07/92017/01/192016/04/32016/12/32017/01/32017/05/122015/04/222016/07/242017/04/32017/08/72017/02/25
1395/12/7
2017/09/232017/09/232017/04/292017/05/12017/05/72017/07/222017/03/122017/05/132017/06/132017/08/122017/08/192017/06/182017/10/302017/05/29
1396/3/8
Golnaz
Fallah
Student Research Committee, Babol University of Medical Sciences, Babol, Iran
dr.mouodi@gmail.com
00319475328460011197
00319475328460011197
No
Sussan
Moudi
Cancer Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
sussan.mouodi@gmail.com
00319475328460011198
00319475328460011198
Yes
Angela
Hamidia
Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
angela_7633@yahoo.com
00319475328460011199
00319475328460011199
No
Ali
Bijani
Non-Communicable Pediatric Diseases Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
alibijani@yahoo.com
00319475328460011200
00319475328460011200
No
en
Performance of electrophysiologic study in an asymptomatic patient with type 2 intermittent Brugada syndrome: To do or not to do?
Background: Brugada syndrome (BrS) is an inherited channelopathy, which is associated with sudden cardiac death due to rapid polymorphic VT or VF. There is no definite consensus regarding the management of asymptomatic patients. Some experts advocate close follow-up; others propose the programmed stimulation for risk stratification. We aimed to evaluate the benefit of complete atrial and ventricular stimulation in patients with BrS and palpitation.
Case Presentation: A 30-year-old man was admitted to our hospital because of a family history of sudden cardiac death (SCD) at age less than 45 years. He complained of self-terminated episodes of palpitation with no history of syncope. Baseline ECG showed incomplete right bundle branch block (RBBB) and saddle-back-like ST deviation in V1. Flecainide challenge test (FCT) revealed Brugada pattern. Complete EPS was done for evaluation of VT/VF inducibility and probable concomitant supraventricular arrhythmias.
Programmed atrial stimulation showed inducible typical slow-fast AVNRT with AH jump 75 msec. Successful slow pathway ablation was done. There was no inducible ventricular arrhythmia.
Conclusions: Patients with drug-induced BrS, positive family history of SCD and also episodes of palpitation, benefit from complete EPS. However, ICD implementation is not recommended in asymptomatic patients with drug-induced BrS and negative EPS for ventricular stimulation
Brugada syndrome, Supraventricular Tachycardia, electrophysiology study
92
95
http://caspjim.com/browse.php?a_code=A-10-677-1&slc_lang=en&sid=1
2017/01/232017/04/162016/10/212016/07/92017/01/192016/04/32016/12/32017/01/32017/05/122015/04/222016/07/242017/04/32017/08/72017/02/252016/12/16
1395/9/26
2017/09/232017/09/232017/04/292017/05/12017/05/72017/07/222017/03/122017/05/132017/06/132017/08/122017/08/192017/06/182017/10/302017/05/292017/03/6
1395/12/16
Kaveh
Hossieni
Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
Kaveh_hosseini130@yahoo.com
00319475328460011201
00319475328460011201
No
Mojtaba
Jahangiri
Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
drmj58@yahoo.com
00319475328460011202
00319475328460011202
No
Ali
Vasheghani-Farahani
Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
avasheghani@tums.ac.ir
00319475328460011203
00319475328460011203
Yes
en
Association of Limb-Girdle muscular dystrophy with multiple sclerosis: A case report
Background: The association of limb-girdle muscular dystrophy (LGMD) with other neurological disorders is uncommon.
Case presentation: We report a 25-year-old female with LGMD who suffered from slowly progressive proximal muscular weakness and atrophy since she was 12 years of age. The patient recently presented with acute loss of left side visual acuity. After evaluation, findings were suggestive of multiple sclerosis.
Conclusions: This is the first report of LGMD in association with MS. The simultaneous occurrence of MS with myopathies may be incidental but there may be a genetic susceptibility for both diseases. This comorbidity may influence the treatment of MS
Limb-Girdle Muscular Dystrophy, Multiple Sclerosis, Myopathy
96
99
http://caspjim.com/browse.php?a_code=A-10-646-1&slc_lang=en&sid=1
2017/01/232017/04/162016/10/212016/07/92017/01/192016/04/32016/12/32017/01/32017/05/122015/04/222016/07/242017/04/32017/08/72017/02/252016/12/162016/10/24
1395/8/3
2017/09/232017/09/232017/04/292017/05/12017/05/72017/07/222017/03/122017/05/132017/06/132017/08/122017/08/192017/06/182017/10/302017/05/292017/03/62017/01/2
1395/10/13
Mahsa
Arzani
Department of Neurology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
mahsaarzani@gmail.com
00319475328460011204
00319475328460011204
No
Hamed
Rezaei
Department of Urology, Sina Hospital, Tehran University of Medical Sciences; Tehran; Iran
hamed109@gmail.com
00319475328460011205
00319475328460011205
No
Abdorreza
Naser Moghadasi
Sina MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
abdorrezamoghadasi@gmail.com
00319475328460011206
00319475328460011206
Yes
en
Sarcoidosis and spondyloarthritis: A coincidence or common etiopathogenesis?
Background: Sarcoidosis is a multisystem granulomatous disease. Co-existence with spondyloarthritis (SA) has been more described as an adverse effect of anti-TNF α therapy than an association. We report herein a case of a typical sarcoidosis confirmed by histological proofs and an advanced SA with a bamboo column.
Case Presentation: A 48-years-old woman presented with inflammatory back pain for 5 years and ankle swelling for 1 year. On physical examination, she had an exaggerated dorsal kyphosis and disappearance of lumbar lordosis with limitation in motion of the cervical and lumbar spine. Laboratory tests did not show an inflammatory syndrome or hypercalcemia. Plain radiographies of the spine and pelvic revealed a triple ray appearance with sacroiliitis grade 4. Chest radiography and CT confirmed the presence of bilateral hilar lymph nodes and parenchymal nodes. Bronchoscopy and biopsies were performed showing non-calcified granulomatous reaction without cell necrosis. The diagnosis of SA was performed based on 9 points of Amor criteria associated with pulmonary sarcoidosis. She was treated with 15 mg per week of methotrexate and 1mg/kg/day of prednisone for pulmonary disease with good outcomes.
Conclusions: Sarcoidosis may be associated to SA besides paradoxical drug effect. The same physio pathological pathways mediate by TNF α are arguments for association than hazardous coincidence
Sarcoidosis, Ankylosing Spondylarthritis, Tumor Necrosis Factor Alpha
100
103
http://caspjim.com/browse.php?a_code=A-10-613-2&slc_lang=en&sid=1
2017/01/232017/04/162016/10/212016/07/92017/01/192016/04/32016/12/32017/01/32017/05/122015/04/222016/07/242017/04/32017/08/72017/02/252016/12/162016/10/242016/09/2
1395/6/12
2017/09/232017/09/232017/04/292017/05/12017/05/72017/07/222017/03/122017/05/132017/06/132017/08/122017/08/192017/06/182017/10/302017/05/292017/03/62017/01/22017/03/13
1395/12/23
Wafa
Hamdi
Department of Rheumatology, Kassab Institute of Orthopedics, Manouba, Tunisia
wafah@yahoo.com
00319475328460011214
00319475328460011214
No
Saoussen
Miladi
Department of Rheumatology, Kassab Institute of Orthopedics, Manouba, Tunisia
saoussenmld@hotmail.com
00319475328460011215
00319475328460011215
Yes
Dhia
Kaffel
Department of Rheumatology, Kassab Institute of Orthopedics, Manouba, Tunisia
Dhkaffel@yahoo.com
00319475328460011216
00319475328460011216
No
Imen
Zouch
Department of Rheumatology, Kassab Institute of Orthopedics, Manouba, Tunisia
zouci@yahoo.fr
00319475328460011217
00319475328460011217
No
Med Montacer
Kchir
Department of Rheumatology, Kassab Institute of Orthopedics, Manouba, Tunisia
kchirm@yahooo.fr
00319475328460011218
00319475328460011218
No
en
A new delivery model to increase adherence to methadone maintenance treatment
Methadone maintenance treatment, Substance abuse, Technology
104
105
http://caspjim.com/browse.php?a_code=A-10-723-4&slc_lang=en&sid=1
2017/01/232017/04/162016/10/212016/07/92017/01/192016/04/32016/12/32017/01/32017/05/122015/04/222016/07/242017/04/32017/08/72017/02/252016/12/162016/10/242016/09/22017/05/3
1396/2/13
2017/09/232017/09/232017/04/292017/05/12017/05/72017/07/222017/03/122017/05/132017/06/132017/08/122017/08/192017/06/182017/10/302017/05/292017/03/62017/01/22017/03/132017/07/5
1396/4/14
Saeid
Komasi
Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
s_komasi63@yahoo.com
00319475328460011219
00319475328460011219
No
Mozhgan
Saeidi
Cardiac Rehabilitation Center, Imam Ali Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
m_saeidi20@yahoo.com
00319475328460011220
00319475328460011220
No
Payam
Sariaslani
Neurology Department, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
psas1149@yahoo.com
00319475328460011221
00319475328460011221
No
Ali
Soroush
Lifestyle Modification Research Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
alisoroush.kums@yahoo.com
00319475328460011222
00319475328460011222
Yes